News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Narhex Board Ousts MD
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sydney anti-viral drug developer Narhex Life Sciences (ASX:NLS) has relocated its head office to Melbourne following the resignation of founder and managing director John Majewski.
Twitter
LinkedIn
Facebook
Email
Print
People
Real estate
MORE ON THIS TOPIC
Psychedelics
All eyes on psychedelic drugmakers as Definium, Compass near major catalysts
August 10, 2026
·
3 min read
·
Gabrielle Masson
Manufacturing
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
August 10, 2026
·
2 min read
·
Nick Paul Taylor
IPO
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs
August 10, 2026
·
5 min read
·
Tristan Manalac
Pipeline
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication
August 10, 2026
·
2 min read
·
Tristan Manalac
